News Release

March 31, 2021

FUJIFILM Holdings establishes new organizations for Healthcare, Imaging, and Graphic fields

Accelerating the generation of further synergies and new businesses in each business field

TOKYO, March 31, 2021 – FUJIFILM Holdings Corporation (President: Kenji Sukeno) establishes new organizations for Healthcare, Imaging, and Graphic fields to accelerate the generation of further synergies and new businesses in each business field.

1. Healthcare Field (Effective date: April 1, 2021)

Reorganization will take place to further accelerate the expansion of healthcare business, a growth driver of Fujifilm. This involves a division into the Medical System, mainly consisting of medical devices for diagnoses, and the Life Sciences*1, covering businesses such as Bio CDMO and drug development support. The Life Sciences Strategy Headquarters will be newly established to lead the businesses for the Life Sciences.

The Life Sciences Strategy Headquarters will plan and promote a comprehensive, integrated strategy including business portfolio management, M&A, alliances and R&D, to generate further synergies and new businesses within its business field. In addition to the Bio CDMO Division and the Pharmaceutical Products Division, the Life Sciences Business Division will be newly established to enhance business for drug development support, by integrating the iPS cell, cell culture media and reagent businesses, which are currently separated in the Regenerative Medicine Business Division and the Fine Chemical Business Division. The current Life Science Products Division, handling cosmetics and supplements, will be renamed to the Consumer Healthcare Business Division. 

Fujifilm hereby reorganizes and strengthens its Life Sciences businesses from a customer perspective, to prioritize businesses for Bio CDMO and drug development support, which are expected to experience high growth in the medium to long term. The overall purpose of this change is to become a leader within the life science industry, by offering value of end-to-end solution as a company strongly supporting the creation of cutting-edge medicine.

  • *1 The Life Sciences consist of the Bio CDMO Division, the Life Sciences Business Division (including iPS cell, cell culture media and reagent), the Pharmaceutical Products Division, and the Consumer Healthcare Business Division (including cosmetics and supplements).
[Image]Healthcare Field

2. Imaging Field (Effective date: April 1, 2021)

The Photo Imaging Products Division and the Optical Device & Electronic Imaging Products Division will be integrated into the Imaging Solutions Division in order to continue offering new value and products that cater to diversifying needs in images and videos.

The needs for images and videos from the society and daily life are diversifying amidst rapid advancement in various technologies, as seen in the diversification of image-recording devices such as smartphones, introduction of high-speed 5G network, advancement in AI technology and progress toward data-oriented society. Fujifilm is redefining the market from broader perspectives in integrating the two business divisions to accelerate the development of new products and services based on its brand power as a comprehensive photo imaging company as well as technological assets that cover fields ranging from imaging devices to photo printing systems and services.

3. Graphic Field (Effective date: July 1, 2021)

In order to accelerate the creation of group-wide synergy and offer even greater values to the printing industry globally, Fujifilm’s Graphic Systems Business Division and Fuji Xerox’s (to change its corporate name to FUJIFILM Business Innovation on April 1) Graphic Communication Services Business Group will be integrated into the Graphic Communication Business Division to be established as of July 1 this year (date of establishment to be confirmed).

Fujifilm’s Graphic Systems business, which boasts far-reaching customer base primarily in commercial printing and packaging printing, will be combined with the marketing, technological and product strengths of FUJIFILM Business Innovation’s Production business, whose strength lies in digital printing technology. The integration allows Fujifilm to deploy end-to-end solutions covering both analogue and digital printing*2 to become the industry’s driving force toward digitization.

  • *2 End-to-end delivery of production printers based on FUJIFILM Business Innovation’s xerography technology, as well as Fujifilm’s Jet Press series of inkjet digital press, wide-format inkjet printers, digital press for the packaging market and printing tools and materials.


Media Contact

FUJIFILM Holdings Corporation
Corporate Communications Division Public Relations Group

  • * Please note that the contents in this website are current as of the date of the press announcement and may be subject to change without prior notice. Information in each release, including the product availability, specification, prices, contacts, are those at the time of publication.